FILINGS
| EPIX 0001633932 | |||
|---|---|---|---|
| Filing Date | Form Type | Description | Document |
| 2024-03-28 | 4 | View Document | |
| 2024-03-28 | 4 | View Document | |
| 2024-03-28 | 4 | View Document | |
| 2024-03-28 | 4 | View Document | |
| 2024-03-07 | 8-K | FORM 8-K | View Document |
| 2024-03-05 | 4 | PRIMARY DOCUMENT | View Document |
| 2024-02-14 | SC 13G/A | SC 13G/A | View Document |
| 2024-02-14 | SC 13G | ESSA PHARMA INC. | View Document |
| 2024-02-13 | 10-Q | 10-Q | View Document |
| 2024-02-13 | 8-K | FORM 8-K | View Document |
| 2024-02-13 | SC 13G/A | SC 13G/A | View Document |
| 2024-02-08 | SC 13G | MS INITIAL | View Document |
| 2024-02-07 | 4 | FORM 4 SUBMISSION | View Document |
| 2024-02-06 | 4 | FORM 4 SUBMISSION | View Document |
| 2024-01-29 | 8-K | FORM 8-K | View Document |
| 2024-01-26 | DEFA14A | DEFA14A | View Document |
| 2024-01-26 | DEF 14A | DEF 14A | View Document |
| 2024-01-23 | SC 13G/A | AMENDMENT NO. 6 | View Document |
| 2024-01-17 | 4 | FORM 4 SUBMISSION | View Document |
| 2024-01-16 | 144 | View Document | |
| 2024-01-16 | 4 | FORM 4 SUBMISSION | View Document |
| 2024-01-08 | 4 | FORM 4 SUBMISSION | View Document |
| 2024-01-05 | 144 | View Document | |
| 2023-12-18 | 4 | 4 | View Document |
| 2023-12-12 | 8-K | FORM 8-K | View Document |
| 2023-12-12 | 10-K | 10-K | View Document |
| 2023-11-24 | 4 | 4 | View Document |
| 2023-11-22 | 4 | 4 | View Document |
| 2023-11-16 | 4 | 4 | View Document |
| 2023-11-06 | 8-K | FORM 8-K | View Document |
| 2023-11-06 | 424B5 | 424B5 | View Document |
| 2023-10-27 | 8-K | FORM 8-K | View Document |
| 2023-10-23 | 8-K | FORM 8-K | View Document |
| 2023-10-10 | EFFECT | View Document | |
| 2023-10-06 | CORRESP | View Document | |
| 2023-10-06 | CORRESP | View Document | |
| 2023-10-03 | CORRESP | View Document | |
| 2023-10-03 | S-3/A | FORM S-3/A | View Document |
| 2023-09-26 | UPLOAD | View Document | |
| 2023-09-19 | S-3 | FORM S-3 | View Document |
| 2023-09-18 | 8-K | FORM 8-K | View Document |
| 2023-09-18 | 8-K | FORM 8-K | View Document |
| 2023-08-08 | 8-K | FORM 8-K | View Document |
| 2023-08-08 | 10-Q | 10-Q | View Document |
| 2023-06-06 | 3 | FORM 3 SUBMISSION | View Document |
| 2023-06-06 | 8-K | FORM 8-K | View Document |
| 2023-05-09 | 8-K | FORM 8-K COVER PAGE | View Document |
| 2023-05-09 | 10-Q | 10-Q | View Document |
| 2023-04-12 | 8-K | FORM 8-K | View Document |
| 2023-03-10 | 8-K | FORM 8-K | View Document |
| 2023-02-14 | SC 13G/A | SC 13G/A | View Document |
| 2023-02-14 | SC 13G/A | SC 13G/A | View Document |
| 2023-02-14 | SC 13G/A | AMENDMENT NO. 5 | View Document |
| 2023-02-14 | SC 13G/A | View Document | |
| 2023-02-14 | SC 13G/A | SC 13G/A | View Document |
| 2023-02-14 | SC 13G/A | ESSA PHARMA INC. | View Document |
| 2023-02-09 | SC 13G/A | JHG PLC OWNS <5% | View Document |
| 2023-02-07 | 8-K | FORM 8-K | View Document |
| 2023-02-07 | 10-Q | 10-Q | View Document |
| 2023-01-24 | DEF 14A | DEF 14A | View Document |
| 2023-01-05 | 4 | FORM 4 SUBMISSION | View Document |
| 2023-01-05 | 4 | FORM 4 SUBMISSION | View Document |
| 2023-01-05 | 4 | FORM 4 SUBMISSION | View Document |
| 2022-12-13 | 8-K | FORM 8-K | View Document |
| 2022-12-13 | 10-K | 10-K | View Document |
| 2022-11-10 | SC 13G | SC 13G | View Document |
| 2022-11-01 | 4 | FORM 4 SUBMISSION | View Document |
| 2022-11-01 | 4 | FORM 4 SUBMISSION | View Document |
| 2022-11-01 | 4 | FORM 4 SUBMISSION | View Document |
| 2022-11-01 | 4 | FORM 4 SUBMISSION | View Document |
| 2022-11-01 | 4 | FORM 4 SUBMISSION | View Document |
| 2022-11-01 | 4 | FORM 4 SUBMISSION | View Document |
| 2022-11-01 | 4 | FORM 4 SUBMISSION | View Document |
| 2022-11-01 | 4 | FORM 4 SUBMISSION | View Document |
| 2022-11-01 | 4 | FORM 4 SUBMISSION | View Document |
| 2022-11-01 | 4 | FORM 4 SUBMISSION | View Document |
| 2022-11-01 | 4 | FORM 4 SUBMISSION | View Document |
| 2022-10-31 | 8-K | FORM 8-K | View Document |
| 2022-10-28 | 4 | FORM 4 SUBMISSION | View Document |
| 2022-10-27 | SC 13G | View Document | |
| 2022-10-26 | 8-K | FORM 8-K | View Document |
| 2022-09-21 | 3 | FORM 3 SUBMISSION | View Document |
| 2022-09-13 | 8-K | FORM 8-K | View Document |
| 2022-08-04 | 10-Q | 10-Q | View Document |
| 2022-08-04 | 8-K | FORM 8-K | View Document |
| 2022-07-21 | 3 | OWNERSHIP DOCUMENT | View Document |
| 2022-07-20 | 4 | FORM 4 SUBMISSION | View Document |
| 2022-07-18 | 4 | FORM 4 SUBMISSION | View Document |
| 2022-07-12 | SC 13G/A | AMENDMENT NO. 6 TO THE SCHEDULE 13G | View Document |
| 2022-07-05 | 4 | FORM 4 SUBMISSION | View Document |
| 2022-06-27 | 8-K | FORM 8-K | View Document |
| 2022-05-10 | 8-K | FORM 8-K | View Document |
| 2022-05-10 | 10-Q | 10-Q | View Document |
| 2022-04-28 | 4 | FORM 4 SUBMISSION | View Document |
| 2022-03-10 | 8-K | FORM 8-K | View Document |
| 2022-02-14 | SC 13G/A | AMENDMENT NO. 5 TO THE SCHEDULE 13G | View Document |
| 2022-02-14 | SC 13G/A | SC 13G/A | View Document |
| 2022-02-14 | SC 13G/A | ESSA PHARMA INC | View Document |
| 2022-02-11 | SC 13G/A | AMENDMENT NO. 1 TO SCHEDULE 13G | View Document |
| 2022-02-11 | SC 13G/A | SC 13G/A ESSA PHARMA | View Document |
Search company filings and access detailed reports including 10-K, 10-Q, 8-K, and other critical filings. Stay informed on corporate disclosures, regulatory filings, and updates with our easy-to-use EDGAR API filings search tool.
